Dec 2018: TRiP-KO stocks will now be made using the pCFD6 vector, in which two guides are expressed under the control of a UAS promoter. These stocks are suitable for both somatic and germline KO. Please contact Jonathan Zirin (firstname.lastname@example.org) with any questions.
Apr 2018: issue with submitting new nominations has been resolved. Nominations can be submitted as normal.
Dec 2017: TRiP-OE stocks are now being made in the flySAM2.0 (VTPHG) vector instead of pCFD4. flySAM2.0 induces higher levels of gene overexpression and only requires a single gRNA design. flySAM2.0 also includes a UAS-dCas9 activator so that any Gal4 line can be crossed to a TRiP-OE line to drive gene overexpression.